PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE

This adverse event was reported 89 times

PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid Emulsion [EPC] 76 0.0288
1 GLP-2 Analog [EPC] 7 0.0005
2 Echinocandin Antifungal [EPC] 2 0.0002
3 Lipopeptide Antibacterial [EPC] 2 0.0002
4 Somatostatin Analog [EPC] 1 0.0001
5 Provitamin D2 Compound [EPC] 4 0.0001
6 Bile Acid [EPC] 3 0.0001
7 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
8 Progesterone [EPC] 2 0.0001
9 Bile Acid Sequestrant [EPC] 1 0.0001
See all drug classes enriched for association with PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE